[Tree] Ozempic's potential in addiction and chronic disease treatment

Version 0.09 (2024-10-28 21:10:14.027000)

updates: New insights on GLP-1 drugs' significance and applications

  • ➔
  • ➔
  • ➔
Version 0.08 (2024-06-20 10:54:38.521000)

updates: New information on Ozempic as a potential treatment for addiction

  • ➔
  • ➔
Version 0.07 (2024-05-19 04:56:56.595000)

updates: Added information about protein gel developed at ETH Zurich

  • ➔
Version 0.06 (2023-12-04 01:53:27.787000)

updates: Information about Ozempic's potential in reducing alcohol cravings

  • ➔
Version 0.05 (2023-11-20 06:20:18.556000)

updates: Incorporated information about the impact of Ozempic on US retail and consumer health

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.04 (2023-10-08 15:49:36.037000)

updates: The new narrative includes information about the shortage of Ozempic in Canada and its impact on patients, as well as the impact of Ozempic on food sales and the presence of counterfeit packages in Germany.

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.03 (2023-10-08 15:45:20.027000)

updates: Added information about Ozempic shortage and its impact on patients with diabetes

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.02 (2023-10-08 15:18:56.837000)

updates: Added information about other products containing similar hormones

  • ➔
  • ➔
  • ➔
  • ➔
Version 0.01 (2023-10-08 15:17:25.919000)

updates: The new narrative focuses on the impact of Ozempic on food sales in the US and includes information about counterfeit Ozempic packages in Germany.

  • ➔
  • ➔
  • ➔
Version 0.0 (2023-10-08 15:12:57.123000)

updates:

  • ➔
  • ➔
  • ➔
  • ➔